Inventor · disambiguated record
Christopher Theile
Also filed as: THEILE CHRISTOPHER · THEILE CHRISTOPHER S
4 granted patents·11 pending applications·18 citations·filing 2017–2025
66Inventor score
Files withALNYLAM PHARMACEUTICALS INC15
Top patents by PatentIndex Score
15 records- 0196US11504391B1Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Nov 22, 2022·18 cites·42 claims
- 0283US12005074B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Jun 11, 2024·0 cites·28 claims
- 0383US2024358738A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0476US2023256001A1Modified rna agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0570US12397013B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Aug 26, 2025·0 cites·66 claims
- 0669US2025205272A1Modified rna agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0767US2022177885A1Endosomal cleavable linkersALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0863US2025382324A1Monomers and methods for synthesis of modified oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0961US2025075217A1Peptide ligands for cns and ocular delivery of rnai compoundsALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1058US2025270562A1Bis-rnai compounds for cns deliveryALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1155US2022307024A1Delivery of oligonucleotides to the striatumALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1254US2023257745A1Circular siRNAsALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1352US2023016929A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1450US11286482B2Endosomal cleavable linkersALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Mar 29, 2022·0 cites·19 claims
- 1549US2023049529A1Modified double stranded oligonucleotideALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →